RB homepage

nasdaq stock market trading wall street

If the effort succeeds, the Raleigh, North Carolina-based imaging group would soon begin trading on the Nasdaq under the ticker symbol LMRI. 

Published in Nature Health, the study included mammograms from over 579,000 women treated across 109 imaging sites in four states. 

Sectra radiology solution

The Sweden-based imaging IT and cybersecurity firm said it will deliver its storage solution as a fully managed cloud service to multiple sites. 

merger acquisition M&A business

The publicly traded imaging center operator is adding Kingston-based River Radiology, which has billed itself as the oldest imaging group in Ulster County. 

Medicare data stethoscope healthcare trends graphs finance financials

Oklahoma will use Humata Health, a firm founded by “recovering radiologist” Jeremy Friese, MD, who said he had grown frustrated with the struggles of prior authorization. 

Hologic sign RSNA 2024,

Moody’s noted that Blackstone and TPG are financing the transaction with $12.25 billion in debt, spread across three separate loans. 

Innovation at work

Six years ago, two radiologists with dissimilar backgrounds and divergent clinical interests put their heads together and launched a new practice. One physician was an academic subspecialized in musculoskeletal reads. The other, a private practitioner, concentrated on oncologic imaging. That’s how Transparent Imaging was born, powered by Konica Minolta. 

Sponsored by Konica Minolta

In a private dining room in Miami, something unusual is happening. Leaders from competing imaging centers are openly discussing their best practices—even sharing vendor recommendations and operational strategies that have doubled their volumes while cutting costs in half.

In cooperation with AbbaDox

Around the web

A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen. 

Customers are urged to stop using these devices right away.

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.